new version V2017

death and events prevention

     

TrialStudied treatmentControl treatmentpatientsROBResultNCT

coronary artery disease

aspirin
Cardiff I, 1974aspirinplaceboNegative
CDPA, 1976aspirinplaceboNegative
Cardiff II, 1979aspirinplaceboNegative
Vogel, 1979aspirinplaceboSuggesting
AMIS, 1980aspirinplaceboSuggestingNCT00000491
GAMIS, 1980aspirinplaceboNegative
PARIS, 1980aspirinplaceboNegative
SAPAT, 1992aspirinplacebo Low risk of bias Suggesting
JAMIS, 1999aspirinplaceboSuggesting
clopidogrel
ASCETclopidogrelaspirin Risk of bias NegativeNCT00222261
CAPRIE, 1996clopidogrelaspirin -
dipyridamol
Foulds, 1960dipyridamolplacebo Exploratory -
Zion, 1961dipyridamolplacebo Exploratory -
Dewar, 1961dipyridamolplacebo Exploratory -
Kinsella, 1962dipyridamolplacebo Exploratory -
Leiberman, 1964dipyridamolplacebo Exploratory -
Neumann, 1964dipyridamolplacebo Exploratory -
Atlanta (Sbar), 1967dipyridamolcontrol Exploratory Negative
Becker, 1967dipyridamolcontrol Exploratory Negative
Wirecki, 1967dipyridamolcontrol Exploratory Negative
Igloe, 1970dipyridamolplacebo Exploratory -
PARIS, 1980dipyridamol + aspirinaspirinNegative
PARIS, 1980dipyridamol + aspirinplaceboNegative
PARIS-II, 1986dipyridamol + aspirinplaceboNegative
ticlopidine
Berglund, 1985ticlopidineplacebo Exploratory Negative